© 2022 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
November 2nd 2021
Andrew T. Kuykendall, MD, discusses the potential for momelotinib in the treatment of patients with myelofibrosis.
December 1st 2021
Claire Harrison, MD, FRCP, FRCPath, discusses the current state of treatment in myelofibrosis.
December 13th 2021
This publication reviews challenges associated with the management of myelofibrosis and examines the current and future role of janus-associated kinase inhibitors in the evolving treatment landscape.